Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical Effect and Safety of CCLG-ALL 2008 (high risk group) Protocol in the Treatment of Childhood Mixed Phenotype Acute Leukemia].

Zhongguo shi yan xue ye xue za zhi - 1 Feb 2021

Zheng Yong-Zhi, LE Shao-Hua, Zheng Hao, Hua Xue-Ling, Chen Zai-Sheng, Zheng Ling, Chen Cai, Li Mei, Cai Chun-Xia, Yang Jing-Hui, Chen Yi-Qiao, Gao Qin-Li, Chen Ying-Ying, Pan Li-Li, Li Jian, Hu Jian-Da

Abstract excerpt

OBJECTIVE: To investigate the clinical effect and safety of Chinese Children's Leukemia Group (CCLG)-ALL 2008 (high risk group) protocol in the treatment with childhood Mixed phenotype acute leukemia (MPAL). METHODS: The clinical data of 15 new diagnosed patients with MPAL treated in our hospital from January 2013 to December 2017 were retrospectively analyzed, and received CCLG-ALL 2008 (high risk group)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Leukemia, Myeloid, Acute

Share to Phenotype

Share to Prognosis

Share to Remission Induction

Source

Identifiers

PMID: 33554796
DOI: 10.19746/j.cnki.issn.1009-2137.2021.01.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical Effect and Safety of CCLG-ALL 2008 (high risk group) Protocol in the Treatment of Childhood Mixed Phenotype Acute Leukemia].PMID 33554796Read ↗

Mixed phenotype acute leukemia: Biological profile, clinical characteristic and treatment outcomes: Report of the population-based study.Semantic proximity Read ↗

[Diagnosis and treatment efficacy analysis of 29 children with mixed phenotype acute leukemia].Semantic proximity Read ↗

Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.Semantic proximity Read ↗

Unmanipulated haploidentical hematopoietic stem cell transplantation for mixed phenotype acute leukemia: a single center studySemantic proximity Read ↗

Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT.Semantic proximity Read ↗

Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.Semantic proximity Read ↗

[Immunophenotypic Features and Clinical Prognosis of Patients with Mixed Phenotype Acute Leukemia].Semantic proximity Read ↗

Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia.Semantic proximity Read ↗

Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic StrategiesSemantic proximity Read ↗

Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.Semantic proximity Read ↗

A multicenter single-arm clinical study of Chinese children’s cancer group-acute promyelocytic leukemia-2017 (CCCG-APL-2017) protocolSemantic proximity Read ↗

An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.